FBTAX
Price
$24.02
Change
-$0.47 (-1.92%)
Updated
May 9 closing price
Net Assets
1.37B
LHCTX
Price
$17.61
Change
-$0.19 (-1.07%)
Updated
May 9 closing price
Net Assets
7.12M
Ad is loading...

FBTAX vs LHCTX

Header iconFBTAX vs LHCTX Comparison
Open Charts FBTAX vs LHCTXBanner chart's image
Fidelity Advisor Biotechnology A
Price$24.02
Change-$0.47 (-1.92%)
VolumeN/A
Net Assets1.37B
Lord Abbett Health Care R5
Price$17.61
Change-$0.19 (-1.07%)
VolumeN/A
Net Assets7.12M
FBTAX vs LHCTX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FBTAX vs. LHCTX commentary
May 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBTAX is a Hold and LHCTX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FBTAX has more cash in the bank: 1.37B vs. LHCTX (7.12M). FBTAX pays higher dividends than LHCTX: FBTAX (2.96) vs LHCTX (0.59). FBTAX was incepted earlier than LHCTX: FBTAX (24 years) vs LHCTX (6 years). LHCTX (3.09) is less costly to investors than FBTAX (0.96). LHCTX is a more actively managed with annual turnover of: 88.00 vs. FBTAX (73.00). FBTAX (0) and LHCTX (0) have matching initial minimum investment requirements. LHCTX annual gain was more profitable for investors over the last year : -7.31 vs. FBTAX (-15.89). LHCTX return over 5 years is better than : 5.57 vs. FBTAX (-13.30).
FBTAXLHCTXFBTAX / LHCTX
Total Expense Ratio0.960.78123%
Annual Report Gross Expense Ratio0.963.0931%
Fund Existence24 years6 years-
Gain YTD-11.724-8.945131%
Front Load6%N/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.37B7.12M19,177%
Annual Yield % from dividends2.960.59499%
Returns for 1 year-15.89-7.31218%
Returns for 3 years23.5211.07212%
Returns for 5 years-13.305.57-239%
Returns for 10 years-11.72N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TK7.890.27
+3.54%
Teekay Corporation Ltd
OVV36.140.81
+2.29%
Ovintiv
ICFI86.60-0.84
-0.96%
ICF International
FDMT3.08-0.16
-4.94%
4D Molecular Therapeutics
INDP0.40-0.03
-6.04%
Indaptus Therapeutics